TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
YARW

Yarrow Bioscience Inc

Healthcare · Biotechnology

22.50$ -6.9% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Yarrow Bioscience Inc (YARW) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 24 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet YARW
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
19 98 92 87 76 67 56 45 36 30 26 24
18 96 90 84 74 64 55 44 36 30 26 24
15 31 19 30 16 20 28 22 19 24 25 23
15 93 86 78 70 62 50 40 33 29 25 23
0.3 – – – – – – – – – – –
0.1 – – – – – – – – – – –
7.8 9.0 8.3 12 13 15 12 5.8 4.0 2.4 1.2 1.5
6.4 7.5 6.9 12 13 15 12 5.8 4.0 2.4 1.2 1.5
– 0.1 0.1 0.1 0.1 0.1 0.1 0.0 – – – –
0.7 1.7 2.8 4.5 4.0 2.7 3.5 1.4 1.2 1.0 0.3 0.6
12 89 83 75 64 52 44 39 32 28 25 22
-685 -691 -698 -707 -719 -731 -740 -746 -753 -758 -761 -764
0.1 0.6 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.7 0.9 0.9

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?